The Ministry of Health has yet to give a reason as to why a public advisory was not issued earlier for the recall of Ray ENAP-10 Enalapril Maleate 10mg and 5mg tablets and why the recall was only issued to wholesalers and pharmacists.
This comes as the Ministry had earlier issued a notice to all medicine wholesalers in Fiji regarding the recall of Ray ENAP-10 Enalapril Maleate 10mg and 5mg tablets, following the test conducted on these medications.
They had only advised all pharmacists to cease dispensing the product if it is in their stock and remove it from circulation as soon as possible.
A letter from the Chief Pharmacist, Ilisabeta Pesamino to the pharmacies which was obtained by fijivillage News stated that the manufacturer for these products is UNILINK PHARMA (P)LTD.
The Ministry says results of testing conducted at the Australian Therapeutic Goods Administration Laboratories revealed that the average amount of Enalapril in the listed batches was below the required standard.
They are also urging members of the public who may have used the product and have experienced any adverse effects to seek medical advice from a qualified healthcare professional and report the incident to the Medicines Regulatory Authority by email at FijiMRA@health.gov.fj or by calling 892 1660.
fijivillage News has also asks that if it was an approved medicine, then why was the test not conducted before approval and who will be taken to task regarding this matter.
The listed batches are Ray ENAP-10 Enalapril Maleate 10mg tablets REBT2301 with an expiry date of 31st January 2026 and Ray ENAP-5 Enalapril Maleate 5mg tablets REAT231 with an expiry date of 31st January 2026.
